Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From the coconut farms of the Philippines to refrigerators across the U.S., Vita Coco turns raw coconuts into a global hydration franchise. That supply chain—and the social commitments behind it—surface in every SEC document. If you’ve searched for “Vita Coco SEC filings explained simply” or wondered how sustainability costs flow through the P&L, this page delivers the answers.
Here you will find the “Vita Coco annual report 10-K simplified” to track segment growth in The Americas, the “Vita Coco quarterly earnings report 10-Q filing” that reveals coconut cost inflation, and the “Vita Coco 8-K material events explained” whenever sourcing disruptions arise. Need to monitor management moves? Our dashboard surfaces “Vita Coco insider trading Form 4 transactions,” “Vita Coco Form 4 insider transactions real-time,” and “Vita Coco executive stock transactions Form 4” the moment they hit EDGAR. Corporate governance questions? Scan the “Vita Coco proxy statement executive compensation” to see how bonus targets align with carbon reduction goals. Each document includes concise summaries and real-time alerts.
Stock Titan’s AI distills every note into clear language, so “understanding Vita Coco SEC documents with AI” means you can jump straight to coconut-water revenue, cash flow, or sustainability metrics. Receive instant notifications, compare “Vita Coco earnings report filing analysis” quarter over quarter, and export numbers directly to your models. Save hours and make confident decisions with complete, up-to-date information.
Vita Coco Company, Inc. (COCO)$47.115 per share, with individual trades executed between $46.32 and $47.45. The filing notes these sales were made under a pre-arranged Rule 10b5-1 trading plan. After this transaction, Sadowsky beneficially owns 616,066 Vita Coco common shares directly. He also holds a non-qualified stock option to purchase 27,300 shares at an exercise price of $10.178 per share, which is fully vested and exercisable and expires on 01/02/2030.
The Vita Coco Company, Inc. (COCO) chief sales officer Charles Van Es reported an option exercise and share sale. On 11/17/2025 he exercised 20,000 non-qualified stock options for common stock at an exercise price of $10.178 per share and acquired 20,000 shares. On the same day, he sold 20,000 shares of common stock at $50 per share under a Rule 10b5-1 trading plan. After these transactions, he beneficially owned 84,328 shares of common stock directly, along with multiple option grants that are vested or vest over time through 2035.
Vita Coco Company, Inc. (COCO)11/17/2025, he sold 14,619 shares of common stock at a weighted average price of $50.102 per share and another 26,138 shares at a weighted average price of $50.086 per share, with the latter held indirectly.
After these transactions, Liran beneficially owned 523,722 shares of Vita Coco common stock directly and 636,441 shares indirectly through the Ira Liran 2012 Family Trust. The filing notes that the sales prices reflect weighted averages across multiple trades between $50.00 and $50.47 per share.
Vita Coco Company, Inc. (COCO) Chief Operating Officer Jonathan Burth reported option exercises and share sales of company stock. On 11/17/2025, he exercised 17,666 stock options at an exercise price of $10.178 per share and sold 17,666 common shares in a separate transaction at a weighted average price of $48.684 per share under a Rule 10b5-1 trading plan. The same day, he exercised an additional 20,000 options at $10.178 per share and sold 20,000 shares at a weighted average price of $50.019 per share. Following these transactions, he directly held 76,127 shares of common stock and a significant number of vested and unvested non-qualified stock options with various exercise prices and expiration dates.
Vita Coco Company, Inc. (COCO)5,102 shares of common stock was executed at $44 per share. After this trade, Kirban beneficially owns 127,629 shares directly, 1,479,049 shares indirectly through the Michael Kirban 2010 Trust, and 615,681 shares indirectly through the Michael Kirban Revocable Trust.
Kirban also holds several non-qualified stock options, including 546,000 options with a $10.178 exercise price expiring 12/16/2029 and other grants with exercise prices ranging from $15 to $32.78 and expirations through 03/03/2035. Some options are fully vested and currently exercisable, while others vest in four equal annual installments starting on specified dates.
Vita Coco Company, Inc. (COCO)10,000 shares of common stock at an exercise price of $10.178 per share and then sold 10,000 shares at a weighted average price of $43.7226 per share under a Rule 10b5-1 trading plan. Following these transactions, the reporting person beneficially owned 12,162 shares of common stock directly and held 20,675 stock options, which are fully vested and currently exercisable, with an expiration date of 12/16/2029.
Vita Coco Company, Inc. (COCO) director Ira Liran reported open‑market sales of company stock executed under a Rule 10b5‑1 trading plan. On 11/05/2025, he sold a total of 50,000 shares in two tranches: 20,000 shares at a weighted‑average price of $41.404 and 30,000 shares at a weighted‑average price of $41.407. The sales were completed across multiple transactions within the disclosed price range.
Following these transactions, Liran beneficially owns 538,341 shares directly and 662,579 shares indirectly through the Ira Liran 2012 Family Trust.
Vita Coco (COCO) reported an insider transaction by its Chief Marketing Officer, Jane Prior. On 10/29/2025, she exercised 10,000 stock options at $10.178 per share and, on the same day, sold 10,000 shares at an average price of $45.242. The sales were made pursuant to a Rule 10b5-1 trading plan.
Following these transactions, she beneficially owns 123,666 shares directly. The filing also lists multiple outstanding non‑qualified stock option grants with various exercise prices and expiration dates.
Vita Coco Company, Inc. (COCO) director Ira Liran reported the sale of 40,000 shares of common stock on 10/29/2025 under a Rule 10b5-1 trading plan. The weighted average sale price was $45.577, with individual transactions ranging from $44.07 to $48.00.
Following the transactions, Liran held 558,341 shares directly and 692,579 shares indirectly through the Ira Liran 2012 Family Trust.
FAQ
What is the current stock price of Vita Coco Company (COCO)?
What is the market cap of Vita Coco Company (COCO)?
